POSACONAZOLE STRAGEN 40 mg/ml, oral suspension bottle, 105 ml
Active ingredients: Posaconazole
Commercialized according to BDPMDispensing in France: Prescription only
Oral suspensionbottle, 105 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- POSACONAZOLE STRAGEN 40 mg/mL, suspension buvable
- Pharmaceutical form
- suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon en verre brun avec fermeture de sécurité enfant de 105 mL avec cuillère-mesure graduée à 2,5 mL et 5 mL
- Marketing authorisation holder
- STRAGEN-FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Apr 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64211572CIP73018944CIP133400930189443Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| POSACONAZOLEsuspension | 40 mg · 1 mL de suspension | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.